APA

Kountourakis P., Antoniou G., Papadimitriou K., Vassiliou V., Syrigos D., Philippou M. & Papamichael D. (20150520). Voice disorders induced by bevacizumab administration in an ovarian cancer patient: an underestimated and rare toxicity. : Hematology/oncology and stem cell therapy.

Chicago

Kountourakis P, Antoniou G, Papadimitriou K, Vassiliou V, Syrigos D, Philippou M and Papamichael D. 20150520. Voice disorders induced by bevacizumab administration in an ovarian cancer patient: an underestimated and rare toxicity. : Hematology/oncology and stem cell therapy.

Harvard

Kountourakis P., Antoniou G., Papadimitriou K., Vassiliou V., Syrigos D., Philippou M. and Papamichael D. (20150520). Voice disorders induced by bevacizumab administration in an ovarian cancer patient: an underestimated and rare toxicity. : Hematology/oncology and stem cell therapy.

MLA

Kountourakis P, Antoniou G, Papadimitriou K, Vassiliou V, Syrigos D, Philippou M and Papamichael D. Voice disorders induced by bevacizumab administration in an ovarian cancer patient: an underestimated and rare toxicity. : Hematology/oncology and stem cell therapy. 20150520.